Leading patient, professional organizations announce funding to improve communications, address IBD shared decision-making

April 17, 2018

Funding recipients will address ways to improve shared decision-making and effective health communications.

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

APPs: Enhance your delivery of patient care

March 28, 2018

AGA's popular course for advanced practice providers will be held this summer in Chicago.

AGA Launches New Patient App to Aid in IBD Monitoring and Education

Jan. 23, 2018

Digital offerings designed to enhance IBD care and shared decision making between patients and physicians.

Tell Congress: Protect the Care of and Research for Digestive Disease Patients

Jan. 23, 2018

Join AGA Virtual Advocacy Day — Thursday, Jan. 25.

Digestive Disease Week® (DDW)

Dec. 19, 2017

Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.

Medical Management of Microscopic Colitis

Jan. 18, 2017

Medical Management of Microscopic Colitis

Wrap Up: Key Recommendations from AGA’s 2015 Guidelines

Dec. 16, 2015

Here's your roundup of the six clinical practice guidelines AGA issued in 2015.

VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis

June 19, 2015

We investigated whether vascular endothelial growth factor signaling via its receptor, VEGFR2, regulates senescence and proliferation of tumor cells in mice with colitis-associated cancer.

Twitter & Facebook Roundup

June 17, 2015

Here are the five most-clicked news items from AGA's Twitter and Facebook pages from the first half of June.

Stem Cells for Murine Interstitial Cells of Cajal Suppress Cellular Immunity and Colitis Via Prostaglandin E2 Secretion

May 1, 2015

We investigated whether gut-derived ICC-SCs could also mitigate experimental colitis and studied the mechanisms of ICC-SC–mediated immunosuppression in relation to MSC-induced pathways.

A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis

April 1, 2015

We aimed to estimate the incidence, risk factors, and natural history of IC in a population-based cohort in Olmsted County, Minnesota.

Life-Threatening Complication of Routine Argon Plasma Photocoagulation

Sept. 29, 2014

An Uncommon Complication of Chronic Antibiotics Refractory Pouchitis After Ileal Pouch–Anal Anastomosis for Ulcerative Colitis

Sept. 29, 2014

Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis

Jan. 31, 2014

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

Dec. 30, 2013

Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice

Dec. 30, 2013

Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study

June 28, 2013

The Unfolded Protein Response and Chemical Chaperones Reduce Protein Misfolding and Colitis in Mice

May 16, 2013

Stewart Siyan Cao and colleagues report in Gastroenterology that chemical chaperones, such as the orally active chemical chaperones tauroursodeoxycholate and 4-phenylbutyrate, alleviate different forms of colitis in mice and might be developed for treatment of inflammatory bowel disease.

Risk of Venous Thromboembolism in Patients with IBD

May 16, 2013

H. Yuhara and colleagues report in Alimentary Pharmacology & Therapeutics that inflammatory bowel disease (IBD) is associated with an approximate two-fold increase in the risk of venous thromboembolism.

Unusual Cause of Abdominal Pain

April 23, 2013

CO and HO-1 Prevent Intestinal Inflammation in Mice

April 11, 2013

Publishing in Gastroenterology, Joseph C. Onyiah and colleagues report that colonic heme oxygenase-1 (HO-1) and its metabolic by-product, carbon monoxide (CO), prevent colonic inflammation in mice by promoting bacterial clearance.

Initiating Azathioprine for Crohn's Disease

April 25, 2012

Abdominal Pain and Weight Loss After Adalimumab Therapy

Jan. 23, 2012